| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.2B | $1.1B | $1.0B | $0.7B |
| Cost of Revenue | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Gross Profit | $1.2B | $1.1B | $1.0B | $0.9B | $0.7B | $0.2B |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $0.4B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| Net Income | $0.3B | $0.2B | $0.3B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $0.88 | $0.75 | $1.05 | $0.57 | $0.30 | $0.17 |
| EPS (Diluted) | $0.85 | $0.72 | $1.00 | $0.55 | $0.30 | $0.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $3.6B | $3.4B | $3.3B | $3.2B | $2.7B | $1.1B |
| Current Assets | $0.5B | $0.4B | $0.4B | $0.4B | $0.6B | $0.3B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.3B | $0.1B |
| Total Liabilities | $2.4B | $2.4B | $2.4B | $2.6B | $2.3B | $0.8B |
| Current Liabilities | $1.0B | $0.8B | $0.8B | $0.6B | $0.6B | $0.5B |
| Stockholders' Equity | $1.2B | $1.0B | — | — | $0.4B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.8B | $-1.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.4B | $0.2B | $1.0B | $-0.1B |